全文获取类型
收费全文 | 482篇 |
免费 | 47篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 3篇 |
妇产科学 | 2篇 |
基础医学 | 38篇 |
口腔科学 | 3篇 |
临床医学 | 20篇 |
内科学 | 61篇 |
皮肤病学 | 3篇 |
神经病学 | 21篇 |
特种医学 | 10篇 |
外科学 | 175篇 |
综合类 | 1篇 |
预防医学 | 8篇 |
眼科学 | 12篇 |
药学 | 14篇 |
肿瘤学 | 124篇 |
出版年
2024年 | 2篇 |
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 10篇 |
2020年 | 15篇 |
2019年 | 20篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 21篇 |
2015年 | 10篇 |
2014年 | 27篇 |
2013年 | 30篇 |
2012年 | 48篇 |
2011年 | 45篇 |
2010年 | 21篇 |
2009年 | 18篇 |
2008年 | 31篇 |
2007年 | 33篇 |
2006年 | 28篇 |
2005年 | 23篇 |
2004年 | 17篇 |
2003年 | 19篇 |
2002年 | 30篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有530条查询结果,搜索用时 31 毫秒
81.
BACKGROUND: Craniofacial resection (CFR) for patients over 70 years of age is uncommon. This study examines a cohort of 36 patients who had CFR at a single institution with the aim of reporting mortality, complications, and outcome. METHODS: Thirty-six patients 70 years of age and older were identified from a prospective database of 234 patients who had CFR at a single institution. The median age was 72 years (range, 70-87). Seventeen (47%) patients had had prior single-modality or combined treatment, which included surgery in 14 (40%), radiation in 13 (36%), and chemotherapy in 2 (6%). Thirty-five patients had a malignant tumor and 1 patient a benign tumor; 15 (42%) had high-grade, 17 (47%) intermediate-grade, and 4 (11%) low-grade pathology. The margins of resection were close or microscopically positive in 18 (50%). Adjuvant radiotherapy was given in 15 (42%) and chemotherapy in 1 (3%). Complications were classified into overall, local, central nervous system (CNS), systemic, and orbital. Overall survival (OS) and disease-specific survival (DSS) were determined using the Kaplan-Meier method. Outcomes were compared with patients less than 70 years of age. RESULTS: Postoperative mortality occurred in 6 (17%) patients and postoperative complications occurred in 23 (64%) patients. Local wound complications occurred in 11 (30%), CNS in 12 (33%), systemic in 6 (17%), and orbital in 1 (3%). Postoperative mortality and complications were significantly higher in patients 70 years of age and older compared with patients less than 70 years of age (17% versus 1.5%, p = .0005; 64% versus 36%, p = .003, respectively). With a median follow-up of 27 months (range, 1-237), the 3 year OS and DSS were significantly poorer than patients less than 70 years of age (OS: 53% versus 69%, p = .0004; DSS: 61% versus 70%, p = .01) due to increased medical comorbidity (53% versus 24%, p = .001) and poorer histology (high-, intermediate-, low-grade histology: 42%, 47%, 11% versus 26%, 47%, 27%, p = .05, respectively) in patients over 70 years of age. CONCLUSION: CFR in patients 70 years of age and older is associated with increased mortality, increased incidence of complications, and a poorer overall and disease-specific 3-year survival, compared with patients less than 70 years of age. The survival was likely due to increased medical comorbidity and adverse histology. These factors must be taken into account when considering an elderly patient for craniofacial resection. 相似文献
82.
Joshi J Menon V Vaidean G Mohan S Thomas J Kelly RV Stouffer GA 《The American journal of cardiology》2006,98(3):338-340
To determine whether the decreased rate of restenosis observed with drug-eluting stents (DES) has changed the treatment of patients with recurrent symptoms after stent placement, we compared patients hospitalized with presumed cardiac symptoms within 1 year after placement of either a DES or a bare metal stent (BMS). In this retrospective, single-center study, cases were identified from consecutive patients who received a DES from March 2003 to July 2004 or a BMS from August 2001 to June 2002. No differences were noted in the rate of hospitalization, hospitalization for presumed cardiac symptoms, use of coronary angiography in patients hospitalized for presumed cardiac symptoms, or average interval to hospitalization. In contrast, restenosis and the need for additional revascularization procedures were higher in the BMS group. The primary indication for additional revascularization was restenosis in the BMS group and progression of coronary artery disease in the DES group. In the DES group, the need for revascularization was significantly higher in patients with multi- versus single-vessel coronary artery disease (26% vs 7%, p < 0.05). In conclusion, the rate of hospitalization and use of coronary angiography in patients with recurrent symptoms were similar in patients who received a BMS or DES, despite the decreased rates of restenosis and additional revascularization procedures observed with DESs. 相似文献
83.
Muscle growth in response to large doses (milligrams per kilogram) of beta(2)-adrenergic receptor agonists has been reported consistently. However, such doses may also induce myocyte death in the heart and skeletal muscles and hence may not be safe doses for humans. We report the hypertrophic and myotoxic effects of different doses of clenbuterol. Rats were infused with clenbuterol (range, 1 microg to 1 mg.kg(-1)) for 14 days. Muscle protein content, myofiber cross-sectional area, and myocyte death were then investigated. Infusions of >or=10 microg.kg(-1).d(-1) of clenbuterol significantly (P<0.05) increased the protein content of the heart (12%-15%), soleus (12%), plantaris (18%-29%), and tibialis anterior (11%-22%) muscles, with concomitant myofiber hypertrophy. Larger doses (100 microg or 1 mg) induced significant (P<0.05) myocyte death in the soleus (peak 0.2+/-0.1% apoptosis), diaphragm (peak 0.15+/-0.1% apoptosis), and plantaris (peak 0.3+/-0.05% necrosis), and significantly increased the area fraction of collagen in the myocardium. These data show that the low dose of 10 microg.kg(-1).d(-1) can be used in rats to investigate the anabolic effects of clenbuterol in the absence of myocyte death. 相似文献
84.
Intraoral presentation of Rosai-Dorfman disease: a case report and review of the literature 总被引:1,自引:0,他引:1
Kademani D Patel SG Prasad ML Huvos AG Shah JP 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2002,93(6):699-704
Rosai-Dorfman disease, or sinus histiocytosis with massive lymphadenopathy, is an unusual clinical entity. It classically presents with massive cervical lymphadenopathy, but atypical presentations have been described in the absence of nodal involvement, making diagnosis difficult. We report a case that presented with isolated involvement of the maxillary alveolus and discuss the diagnostic dilemmas and approaches to management in patients with atypical clinical features. 相似文献
85.
Nathan H Fowler R Eric Davis Seema Rawal Loretta Nastoupil Fredrick B Hagemeister Peter McLaughlin Larry W Kwak Jorge E Romaguera Michelle A Fanale Luis E Fayad Jason R Westin Jatin Shah Robert Z Orlowski Michael Wang Francesco Turturro Yasuhiro Oki Linda C Claret Lei Feng Sattva S Neelapu 《The lancet oncology》2014,15(12):1311-1318
86.
This study investigated motivational changes in a 44 year-old man (PJ) who developed considerable reduction in spontaneous activity and speech, flat affect, social withdrawal, loss of interest, inability to "feel," and lack of concern regarding his medical condition after bilateral, focal, anoxic lesions of the globus pallidus. PJ and 30 male controls performed a task designed to parse hedonic evaluation, or liking, from incentive motivation, or wanting. Affective stimuli were presented on a computer screen and subjects controlled viewing time by pressing keys. PJ's liking and wanting of unpleasant stimuli was similar to that of controls. In response to pleasant stimuli, PJ showed normal ratings of wanting and hedonic appreciation, but significantly reduced viewing time or made no responses. Active withdrawal from liked stimuli could constitute the basic mechanism underlying poor motivation and social withdrawal associated with globus pallidus damage. 相似文献
87.
The face mask is a device to facilitate the delivery of gases from a breathing system to a patient by creating an airtight seal around the face. Of the many types of face masks available, the anatomical face mask is most commonly used for anaesthesia. With repeated usage, the seal of the anatomical face mask becomes flattened due to the loss of air in the cushion, leading to a poor fit on the patient's face. This results in air dilution during spontaneous respiration and inadequate gas exchange during controlled ventilation. A simple solution to restore this seal has been provided. 相似文献
88.
89.
Sumit Arora Jatin Talwar Vikramadittya Singh Vikas Gupta 《Indian Journal of Thoracic and Cardiovascular Surgery》2021,37(3):307
Tuberculosis in the tibial diaphysis following saphenous vein graft harvest for coronary artery bypass grafting has not been reported, to the best of authors’ knowledge. We report the first such clinical case in view of its clinical rarity and as a complication of the simple procedure like saphenous vein graft harvest. 相似文献
90.
Leonard Lothstein Judith Soberman Deanna Parke Jatin Gandhi Trevor Sweatman Tiffany Seagroves 《Oncology research》2020,28(5):451-465
Triple-negative breast cancer (TNBC) is unresponsive to antiestrogen and anti-HER2 therapies, requiring the
use of cytotoxic drug combinations of anthracyclines, taxanes, cyclophosphamide, and platinum compounds.
Multidrug therapies achieve pathological cure rates of only 20–40%, a consequence of drug resistance and
cumulative dose limitations necessitated by the reversible cardiotoxic effects of drug therapy. Safer and more
effective treatments for TNBC are required to achieve durable therapeutic responses. This study describes the
mechanistic analyses of the novel anthracycline, pivarubicin, and its in vivo efficacy against human primary
TNBC. Pivarubicin directly activates PKCd, triggers rapid mitochondrial-dependent apoptosis, and circumvents resistance conferred by overexpression of P-glycoprotein, Bcl-2, Bcl-XL, and Bcr-Abl. As a consequence,
pivarubicin is more cytotoxic than doxorubicin against MDA-MB-231, and SUM159 TNBC cell lines grown
in both monolayer culture and tumorspheres. Comparative in vivo efficacy of pivarubicin and doxorubicin was
performed in an orthotopic NSG mouse model implanted with MDA-MB-231 human TNBC cells and treated
with the maximum tolerated doses (MTDs) of pivarubicin and doxorubicin. Tumor growth was monitored by
digital caliper measurements and determination of endpoint tumor weight and volume. Endpoint cardiotoxicity
was assessed histologically by identifying microvacuolization in ventricular cardiomyocytes. Primary tumors
treated with multiple rounds of doxorubicin at MTD failed to inhibit tumor growth compared with vehicletreated tumors. However, administration of a single MTD of pivarubicin produced significant inhibition of
tumor growth and tumor regression relative to tumor volume prior to initiation of treatment. Histological
analysis of hearts excised from drug- and vehicle-treated mice revealed that pivarubicin produced no evidence
of myocardial damage at a therapeutic dose. These results support the development of pivarubicin as a safer and
more effective replacement for doxorubicin against TNBC as well as other malignancies for which doxorubicin
therapy is indicated. 相似文献